Literature DB >> 10766010

Cardiovascular disease and chronic renal disease: a new paradigm.

M J Sarnak1, A S Levey.   

Abstract

Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with chronic renal disease (CRD). Despite Improvement in treatment for CVD over the past 30 years, CVD mortality is approximately 15 times higher in dialysis patients than in the general population. The high prevalence of CVD among Incident dialysis patients suggests that CVD begins in earlier stages of CRD, and that implementation of risk factor reduction strategies earlier in the course of CRD may provide an opportunity to prevent CVD in CRD. Based on parallels between CVD and renal disease progression, we have proposed a paradigm that CVD and CRD are outcomes of the same underlying disorders. We propose that risk factor reduction strategies used to prevent CVD in the general population also be applied to patients with CRD, with the hope of preventing progression of renal disease, as well as preventing CVD.

Entities:  

Mesh:

Year:  2000        PMID: 10766010     DOI: 10.1016/s0272-6386(00)70239-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  98 in total

1.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

2.  Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuria.

Authors:  Matthew R Weir
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

3.  Uncontrolled hypertension in children on hemodialysis.

Authors:  Mark Mitsnefes; Daniel I Feig
Journal:  Nat Rev Nephrol       Date:  2010-01       Impact factor: 28.314

4.  Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

Authors:  Stuart L Goldstein; Douglas M Silverstein; Jocelyn C Leung; Daniel I Feig; Beth Soletsky; Cathy Knight; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

Review 5.  Managing dyslipidemia in chronic kidney disease.

Authors:  Daniel E Weiner; Mark J Sarnak
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

6.  Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients.

Authors:  Jolanta Malyszko; Piotr Kozminski; Jacek Malyszko; Michal Mysliwiec
Journal:  Int Urol Nephrol       Date:  2009-11-12       Impact factor: 2.370

7.  Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anh L Bui; Ronit Katz; Bryan Kestenbaum; Ian H de Boer; Linda F Fried; Joseph F Polak; Bruce A Wasserman; Mark J Sarnak; David Siscovick; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

8.  Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year.

Authors:  François-Pierre Mongeon; Marc Dorais; Jacques Le Lorier; Daniel Froment; Elaine Letendre; Stéphane Rinfret
Journal:  Open Cardiovasc Med J       Date:  2009-06-24

9.  Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study.

Authors:  Tobias Kurth; Paul E de Jong; Nancy R Cook; Julie E Buring; Paul M Ridker
Journal:  BMJ       Date:  2009-06-29

10.  Carotid intima-media thickness in children with end-stage renal disease on dialysis.

Authors:  A Gheissari; M Sirous; T Hajzargarbashi; R Kelishadi; A Merrikhi; A Azhir
Journal:  Indian J Nephrol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.